Association Between Low-Income Subsidies and Inequities in Orally Administered Antimyeloma Therapy Use
Medicare Part D low-income subsidies alone are insufficient to improve the uptake and equitable use of high-cost, orally administered antimyeloma therapy.
Impact of Co-pay Assistance on Patient, Clinical, and Economic Outcomes
Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting improvements in clinical outcomes.
2 Clarke Drive Cranbury, NJ 08512